|Mr. Michael F. Adams||Pres, CEO & Director||336k||N/A||61|
|Ms. Khristine L. Carroll||Exec. VP of Commercial Operations||226k||N/A||44|
|Mr. Michael Szycher Ph.D., MBA||Founder and Sr. Scientific Advisor||N/A||N/A||76|
|Mr. Ajay Nagle||Head of Legal||N/A||N/A||N/A|
|Ms. Jill Knudsen||Gen. Mang. of Catheter & Disposables Technology Inc||N/A||N/A||47|
AdvanSource Biomaterials Corporation develops polymer materials for use in the design and development of medical devices used for treating a range of anatomical sites and disease states. It offers polymers under the ChronoFilm, ChronoFlex, ChronoThane, ChronoPrene, ChronoSil, HydroThane, HydroMed, and PolyBlend trade names. The company also manufactures specialty hydrophilic polyurethanes. It sells its products directly to the customers in the United States. The company was formerly known as CardioTech International, Inc. and changed its name to AdvanSource Biomaterials Corporation in October 2008. AdvanSource Biomaterials Corporation was founded in 1993 and is headquartered in Wilmington, Massachusetts.
AdvanSource Biomaterials Corporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.